Skip to main content

Table 1 Changes from baseline in the Arg16Gly genotype at the end of 12 weeks of treatment with FSC

From: Effect of β2 -adrenergic receptor gene Arg16Gly polymorphisms on response to long-acting β2-agonist in Chinese Han asthmatic patients

ADRB2 marker Morning PEF (L/min) FEV1(L) Albuterol use (puffs/d) Asthma symptom score
Arg16Gly genotype     
ArgArg(n = 21) 114.4 ± 21.5 0.44 ± 0.09 −3.81 ± 1.94 −1.10 ± 0.78
ArgGly(n = 26) 103.3 ± 23.7 0.43 ± 0.07 −3.77 ± 1.95 −0.96 ± 0.53
GlyGly(n = 15) 100.3 ± 14.7 0.45 ± 0.11 −3.80 ± 1.86 −0.93 ± 0.59
  1. No significant difference.